From EpiPens to EpiGenetics: Understanding the Mechanisms Behind the Microbiome’s Impact on Peanut Allergies
ISEF · 2018 Biomedical and Health Sciences
Overview
BACKGROUND: Peanut allergy therapies, such as EpiPens, treat anaphylactic reactions, but do not cure allergies. Previously, altering a monomicrobial microbiome with Bacteroides fragilis dampened the destructive T-cell peanut allergic response (IL-22). However, mechanisms driving the microbiome's alteration of T-cell responses remain unclear. T-cells are regulated by checkpoint proteins PD-1 and BTLA. T-cells can also produce the reparative cytokine IL-33. Recent data has shown epigenetic changes (DNA methylation) may explain individualized responses in varying diseases. I hypothesize Bacteroides impacts a combination of phenotypic and epigenetic changes. METHODS: T-cells were cultured in mono- or polymicrobial environments, dominated in Clostridium(C50), Bacteroides(B50), or Lactobacillus(L50). ELISA measured IL-22 over varying time points and IL-33. Global epigenetic changes(5-methylcytosine) were measured by ELISA. PD-1 and BTLA expression was measured by flow cytometry. RESULTS: Allergic reactions produce biphasic IL-22 responses, suggesting it is both preformed and de novo synthesized. Bacteroides dampened IL-22 and elevated IL-33 in a monomicrobial environment. In polymicrobial environments, C50 decreased IL-22, and C50 and B50 elevated IL-33. Only Bacteroides decreases PD-1 and BTLA expression, and induced a PD-1 high response.Peanut allergy induced T-cell epigenetic changes, which were decreased by both Bacteroides and B50. CONCLUSION: In mono- and polymicrobial environments, Bacteroides impacts allergic reactions producing a combination of protective T-cell phenotypes, cytokines, and epigenetic changes, while reducing the destructive IL-22 levels. This data paves the way for a potential cure for peanut allergies by changing the immune/microbiome interactions.
Competition history
- ISEF 2018
Resources
Related projects
ISEF · 2019
Ending the EpiPen Epidemic: Creating an Intestinal Organoid to Understand the Immune Mechanisms Involved in a Peanut Allergy
ISEF · 2021
Butyrate: Bridging Bench to Bedside -- Bringing Hope for Better Diagnostic and Therapeutic Options for Peanut Allergies
ISEF · 2024
Investigating the Impact of Parasitic Worm-Induced Secretions on Anaphylaxis
ISEF · 2026
Modulating a Novel Neuroepithelial Circuit in Food Allergy to Repair Barrier Dysfunction With Larazotide Acetate and Neuregulin-1
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair